社区美沙酮维持治疗门诊中HCV感染者接受抗病毒治疗现状及影响因素

Uptake of HCV treatment and related factors among drug users in community-based methadone maintenance treatment program

抗病毒治疗是降低吸毒人群丙型肝炎病毒(Hepatitis Cvirus,HCV)感染及肝硬化发生的成本效益最优的措施,参加社区美沙酮维持治疗(Methadone maintenance treatment,MMT)人群HCV感染率高达60.1%,但接受抗病毒治疗率及影响因素目前尚不清楚。本文结合国外社区MMT运行模式及丙肝抗病毒治疗方案的应用,系统综述我国社区MMT人群HCV感染者接受抗病毒治疗现状,并从卫生服务提供方角度阐述其影响因素,为社区MMT更好地防控吸毒人群HCV感染提供理论依据。

Antiviral treatment is the most cost-effective measure to curb Hepatitis C virus (HCV) epidemic and prevent liver cirrhosis among drug users. HCV prevalence among Chinese methadone maintenance treatment (MMT) clients was high,but status and barriers for HCV treatment were unclear. This paper summarized the current HCV treatment status and related factors in Chinese MMT program from provider’s perspective,aimed to provide references for future researches.